Serum amyloid A1 exacerbates hepatic steatosis via TLR4-mediated NF-κB signaling pathway
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Serum amyloid A1 exacerbates hepatic steatosis via TLR4-mediated NF-κB signaling pathway
Authors
Keywords
Hepatic steatosis, Non-alcoholic fatty liver disease, NF-κB signaling pathway, Obesity, Serum amyloid A1, Toll-like receptor
Journal
Molecular Metabolism
Volume 59, Issue -, Pages 101462
Publisher
Elsevier BV
Online
2022-03-03
DOI
10.1016/j.molmet.2022.101462
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hepatocytes derived increased SAA1 promotes intrahepatic platelet aggregation and aggravates liver inflammation in NAFLD
- (2021) Daoyuan Li et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease
- (2020) Mohammed Eslam et al. GASTROENTEROLOGY
- TNFAIP3 Interacting Protein 3 Overexpression Suppresses Nonalcoholic Steatohepatitis by Blocking TAK1 Activation
- (2020) Dan Liu et al. Cell Metabolism
- iRhom2 promotes hepatic steatosis by activating MAP3K7‐dependent pathway
- (2020) Minxuan Xu et al. HEPATOLOGY
- Silencing of SAA1 inhibits palmitate- or high-fat diet induced insulin resistance through suppression of the NF-κB pathway
- (2019) Yong Wang et al. MOLECULAR MEDICINE
- Past, present and future perspectives in nonalcoholic fatty liver disease
- (2019) Arun J. Sanyal Nature Reviews Gastroenterology & Hepatology
- Major vault protein suppresses obesity and atherosclerosis through inhibiting IKK–NF-κB signaling mediated inflammation
- (2019) Jingjing Ben et al. Nature Communications
- Serum amyloid A levels in patients with liver diseases
- (2019) Zi-Ying Yuan et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Serum Amyloid A Proteins Induce Pathogenic Th17 Cells and Promote Inflammatory Disease
- (2019) June-Yong Lee et al. CELL
- TRUSS exacerbates NAFLD development by promoting IκBα degradation
- (2018) Chang-Jiang Yu et al. HEPATOLOGY
- Improvement of hepatic fibrosis and patient-reported outcomes in non-alcoholic steatohepatitis treated with selonsertib
- (2018) Zobair M. Younossi et al. LIVER INTERNATIONAL
- Mechanisms of NAFLD development and therapeutic strategies
- (2018) Scott L. Friedman et al. NATURE MEDICINE
- Serum amyloid A promotes LPS clearance and suppresses LPS‐induced inflammation and tissue injury
- (2018) Ni Cheng et al. EMBO REPORTS
- Global Perspectives on Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis
- (2018) Zobair Younossi et al. HEPATOLOGY
- Serum amyloid A – a review
- (2018) George H. Sack MOLECULAR MEDICINE
- Role of Innate Immune Signaling in Non-Alcoholic Fatty Liver Disease
- (2018) Jingjing Cai et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
- (2017) Naga Chalasani et al. HEPATOLOGY
- Liver inflammation and fibrosis
- (2017) Yukinori Koyama et al. JOURNAL OF CLINICAL INVESTIGATION
- Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
- (2017) Zobair Younossi et al. Nature Reviews Gastroenterology & Hepatology
- Pro-inflammatory hepatic macrophages generate ROS through NADPH oxidase 2 via endocytosis of monomeric TLR4–MD2 complex
- (2017) So Yeon Kim et al. Nature Communications
- Nonalcoholic Fatty Liver Disease: Pathogenesis and Disease Spectrum
- (2016) Timothy Hardy et al. Annual Review of Pathology-Mechanisms of Disease
- Efficacy and safety study of cenicriviroc for the treatment of non-alcoholic steatohepatitis in adult subjects with liver fibrosis: CENTAUR Phase 2b study design
- (2016) Scott Friedman et al. Contemporary Clinical Trials
- The cytokine-serum amyloid A-chemokine network
- (2016) Mieke De Buck et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Serum amyloid A links endotoxaemia to weight gain and insulin resistance in mice
- (2016) Edson M. de Oliveira et al. DIABETOLOGIA
- Serum amyloid A1: Structure, function and gene polymorphism
- (2016) Lei Sun et al. GENE
- Pathobiology of liver fibrosis: a translational success story
- (2015) Youngmin A Lee et al. GUT
- Emerging functions of serum amyloid A in inflammation
- (2015) Richard D. Ye et al. JOURNAL OF LEUKOCYTE BIOLOGY
- CXCL10 plays a key role as an inflammatory mediator and a non-invasive biomarker of non-alcoholic steatohepatitis
- (2014) Xiang Zhang et al. JOURNAL OF HEPATOLOGY
- Serum Amyloid A Induces CCL2 Production via Formyl Peptide Receptor-Like 1-Mediated Signaling in Human Monocytes
- (2014) H. Y. Lee et al. JOURNAL OF IMMUNOLOGY
- Cutting Edge: TLR2 Is a Functional Receptor for Acute-Phase Serum Amyloid A
- (2014) N. Cheng et al. JOURNAL OF IMMUNOLOGY
- Structural mechanism of serum amyloid A-mediated inflammatory amyloidosis
- (2014) J. Lu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hepatocyte Toll-like receptor 4 regulates obesity-induced inflammation and insulin resistance
- (2014) Lin Jia et al. Nature Communications
- SAA does not induce cytokine production in physiological conditions
- (2012) Myung-Hee Kim et al. CYTOKINE
- Acute-Phase Serum Amyloid A Protein and Its Implication in the Development of Type 2 Diabetes in the KORA S4/F4 Study
- (2012) C. Marzi et al. DIABETES CARE
- CD14 Controls the LPS-Induced Endocytosis of Toll-like Receptor 4
- (2011) Ivan Zanoni et al. CELL
- Serum Amyloid A Activates the NLRP3 Inflammasome and Promotes Th17 Allergic Asthma in Mice
- (2011) J. L. Ather et al. JOURNAL OF IMMUNOLOGY
- Serum Amyloid A Induces Lipolysis by Downregulating Perilipin Through ERK1/2 and PKA Signaling Pathways
- (2011) Lih R. Liu et al. Obesity
- Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: The central role of nontriglyceride fatty acid metabolites
- (2010) Brent A. Neuschwander-Tetri HEPATOLOGY
- Targeting major vault protein in senescence-associated apoptosis resistance
- (2009) Sung Jin Ryu et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- The structural basis of lipopolysaccharide recognition by the TLR4–MD-2 complex
- (2009) Beom Seok Park et al. NATURE
- Is serum amyloid A an endogenous TLR4 agonist?
- (2008) Silvana Sandri et al. JOURNAL OF LEUKOCYTE BIOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started